Dr Nguyen is a superstar and leading innovation in the machine perfusion space, and took a simple idea - biomarker indicators at discrete time points miss information that can be valuable - and is translating that into a device that could be applied in-line with a circuit for a wide palette of markers, which may assist surgeons in organ selection, prognostication, and ultimately improve access to transplant.
Excited to share that our work on the DCBM (dual-compartment biochemical monitoring) platform normothermic machine perfusion (NMP) is now published in Nature Communications. @NaturePortfolio . rdcu.be/ftJnKView quoted post on X
This platform enables real-time simultaneous analysis of perfusate and bile during NMP, giving us better tools to assess organ viability and support clinical decision-making for liver transplantation.
This was a strong partnership between @MayoClinic
and @TerasakiInst for Biomedical Innovation. Grateful for the close collaboration with Dr. Yangzhi Zhu, whose work with his team at Terasaki made this platform possible.
Thank you to Dr. @aqel_bashar , Chair of Transplant, and Dr. @MathurAmitK MD MS FACS MS FACS, Surgical Liver Director, for their guidance and support, and to all our co-authors who contributed to this work.
Looking forward to continuing this collaboration with Dr. Zhu and the Terasaki team as we push toward clinical translation.